Literature DB >> 29868740

Breastfeeding and Future Maternal Health-No Causal Evidence.

Claudia Gragnoli1,2,3, Rongling Wu2,4, Intekhab Ahmed1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29868740      PMCID： PMC5992486          DOI： 10.1001/jamainternmed.2018.1806

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  6 in total

Review 1.  Regulation of beta-cell mass by hormones and growth factors.

Authors:  J H Nielsen; E D Galsgaard; A Møldrup; B N Friedrichsen; N Billestrup; J A Hansen; Y C Lee; C Carlsson
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

2.  Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.

Authors:  Dorte Glintborg; Magda Altinok; Hanne Mumm; Kristian Buch; Pernille Ravn; Marianne Andersen
Journal:  Hum Reprod       Date:  2014-06-04       Impact factor: 6.918

3.  Maternal Serum Prolactin and Prediction of Postpartum β-Cell Function and Risk of Prediabetes/Diabetes.

Authors:  Ravi Retnakaran; Chang Ye; Caroline K Kramer; Philip W Connelly; Anthony J Hanley; Mathew Sermer; Bernard Zinman
Journal:  Diabetes Care       Date:  2016-04-26       Impact factor: 19.112

4.  Decreased glucose stimulation threshold, enhanced insulin secretion, and increased beta cell coupling in islets of prolactin-treated rats.

Authors:  R L Sorenson; M G Johnson; J A Parsons; J D Sheridan
Journal:  Pancreas       Date:  1987       Impact factor: 3.327

5.  Lactation Duration and Progression to Diabetes in Women Across the Childbearing Years: The 30-Year CARDIA Study.

Authors:  Erica P Gunderson; Cora E Lewis; Ying Lin; Mike Sorel; Myron Gross; Stephen Sidney; David R Jacobs; James M Shikany; Charles P Quesenberry
Journal:  JAMA Intern Med       Date:  2018-03-01       Impact factor: 21.873

6.  Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes?

Authors:  Lisa Balbach; Henri Wallaschofski; Henry Völzke; Matthias Nauck; Marcus Dörr; Robin Haring
Journal:  BMC Endocr Disord       Date:  2013-03-21       Impact factor: 2.763
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.